STAGE IVA PANCREATIC CANCER

Clinical trials for STAGE IVA PANCREATIC CANCER explained in plain language.

Never miss a new study

Get alerted when new STAGE IVA PANCREATIC CANCER trials appear

Sign up with your email to follow new studies for STAGE IVA PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Promising combo tackles Hard-to-Treat GI cancers

Disease control Completed

This early-phase trial tested a combination of two drugs—pembrolizumab (an immunotherapy) and XL888 (a targeted therapy)—in 47 people with advanced gastrointestinal cancers that had spread or couldn't be removed. The main goal was to find the safest dose and check for side effect…

Matched conditions: STAGE IVA PANCREATIC CANCER

Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control

Last updated May 26, 2026 10:11 UTC

STAGE IVA PANCREATIC CANCER

Get alerted when new STAGE IVA PANCREATIC CANCER trials appear

Promising combo tackles Hard-to-Treat GI cancers